La Revue Du Praticien N° 08 - 2018

DÉCOUVRIR

HISTOIRE CONTEMPORAINE DE LA MÉDECINE

RÉFÉRENCES 10. Elliot DF, Peart WS. Amino acid sequence Tsunami pathogenesis and management fragment length polymorphism in
1. Skeggs LT. Historical overview of the in a hypertensin. Nature 1956;177:527-8. of hypertensive vascular diseases. hypertensives and normotensive
Am J Med 1972;52:633-52. subjects. Hypertension 1990;16:712-7.
renin-angiotensin system. In Hypertension 11. Skeggs LT, Kahn JR, Lentz KE et al. 18. H aber E, Koerner T, Page LB, et al. 26. J eunemaitre X, Soubrier F, Koteletsev Y,
and the angiotensin system. Doyle AJ The preparation, purification and aminoacid Application of a radioimmunoassay et al. Molecular basis of essential
and Beam AG ed. New York: Raven Press, sequence of a polypeptide renin substrate. for angiotensin I to the physiological hypertension: role of angiotensinogen.
1983:31-44. J Exp Med 1957;106:439-53. measurement of plasma renin activity Cell 1992;71:169-80.
2. P age IH. Hypertension Research. A Memoir in normal human subjects. J Clin Endoc 27. R igat B, Hubert C, Alhenc-Gelas F, et al.
1920-1960. New York: Pergamon Press, 1988. 12. Y ang HYT, Erdös EG, Levin Y. A dipeptidyl Metab 1969; 29:1349-55. An insertion/deletion polymorphism
3. Robertson JIS. Renin and angiotensin: carboxypeptidase converts angiotensin I 19. C orvol P, Ménard J. Renin purification and in the angiotensin I-converting enzyme
a historical review. in The renin angiotensin and inactivates bradykinin. Biochem cloning. Hypertension 1991;18:252-6. accounts for half the variance of serum
system, ed JIS Robertson and MG Nicholls. Biophys Acta 1970;214:374-6. 20. Corvol P, Menard J. De la structure enzyme levels. J Clin Invest 1990;86:1343-6.
Londres: Gower Medical Publishing Group, de la rénine à la conception d’inhibiteurs. 28. M arre M, Hadjadj S, Bouhanick B.
1993:1.1-1.17. 13. Goormaghtigh N. La fonction endocrine Med Sci 1986;2:385-94. Hereditary factors in the development
4. Ménard J. Anthology of the renin-angiotensin des artères rénales : son rôle dans la 21. Ferreira SH. A bradykinin-potentiating of diabetic renal disease. Diabetes Metab
system: a one hundred reference approach pathogénie de l’hypertension artérielle. factor (BPF) present in the venom 2000;26(Suppl 4):30-6.
to angiotensin II antagonists. J Hypertension Rev Belge Sci Med 1945;16:65-155. of Bothrops Jararaca. Br J Pharmacol 29. Krege JH, John SW, Langenbach LL,
1993;11(suppl 3):S3-S11. Ther 1965;24:163-9. et al. Male-female differences in fertility
5. Postel-Vinay N. La découverte du système 14. G ross F, Lichtlen P. Experimental renal 22. C ushman DW, Ondetti MA. History and blood pressure in ACE-deficient mice.
rénine-angiotensine In Impressions artérielles. hypertension: renin content of kidneys of the design of captopril and related Nature 1995;375:146-8.
Paris : Maloine, 1995:79-90. extracts in intact and adrenalectomized inhibitors of angiotensin converting 30. Cole J, Ertoy D, Lin H, et al. Lack
6. T igerstedt R, Bergman PG. Niere und kreislauf. rats given cortexone. Am J Physiol enzyme. Hypertension 1991;17:589-92. of angiotensin II-facilitated erythropoiesis
Scand Arch Physiol1898;8:223-71. 1958;195:543-8. 23. W ong PC, Chiu AT, Price WA, et al. causes anemia in angiotensin-converting
7. Goldblatt H, Lynch J, Hanzal RF, et al. Nonpeptide angiotensin II receptor enzyme-deficient mice. J Clin Invest
The production of persistent elevation 15. G ross F, Schaechtelin G, Brunner H, et al. antagonists. J Pharmacol Exp Ther 2000;106:1391-8.
of systolic blood pressure by means of renal The role of the renin-angiotensin system 1988;247:1-17. 31. M arc Y, Hmazzou R, Balavoine F,
ischemia. J Exp Med 1934;59:347-80. in blood pressure regulation and kidney 24. W ood J, Malbaum J, Rahuel J, et al. et al. Central antihypertensive effects
8. P age IH, Helmer OM. A crystalline substance function. Canad Med Ass J 1964;90:258-62. Structure-based design of aliskiren, of chronic treatment with RB150 :
resulting from the action between renin and a novel orally active renin inhibitor. Biochem an orally active aminopeptidase
renin-activator. J Exp Med 1940;71:29-42. 16. Guyton AC, Hall JE, Coleman TC, et al. Biophys Res Commun 2003;308:698-705. A inhibitor in deoxycorticosterone acetate-salt
9. Braun-Menéndez E, Fasciolo JC, Leloir LF, et The dominant role of the kidney in long-term 25. S oubrier F, Jeunemaitre X, Rigat B, et al. rats. J Hypertension 2018;36:641-50.
al. The substance causing renal hypertension. arterial pressure regulation in normal Similar frequencies of renin gene restriction
J Physiol 1940;98:283-98. and hypertensive states. In: Hypertension.
Pathophysiology, Diagnosis and Management.
Laragh JH and Brenner BM Ed. New York:
Raven Press, 1995:1311-26.

17. L aragh JH, Baer L, Brunner HR, et al. Renin,
angiotensin and aldosterone system in

926 Vol. 68 _ Octobre 2018
TOUS DROITS RESERVES - LA REVUE DU PRATICIEN